Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02439736 · ClinicalTrials.gov registry record
Evaluation OF Biomarkers OF Traumatic Brain Injury Extension Study
A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 119
- Enrollment target
- 7
- Study locations
NCT02439736: Completed study of Traumatic Brain Injury, sponsored by Banyan Biomarkers.
NCT02439736 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 119 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02439736, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 7
- Study locations
Study Summary
The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely with traumatic brain injury (Glasgow Coma Scale score 9-15).
Conditions Studied
Interventions
- OTHER Blood draw within 12 hours of head injury
Study Locations (7)
Virginia
- University of Virginia - Charlottesville
- Virginia Commonwealth University - Richmond
Other
- Ludwig-Maximilians-University - Munich
- Klinikum rechts der Isar of the Technical University of Munich - Munich
California
- University of California San Diego - San Diego
Michigan
- Wayne State University - Detroit Receiving Hospital - Detroit
Texas
- Baylor College of Medicine/Ben Taub General Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-11 |
What the finished NCT02439736 record still lists
NCT02439736 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Blood draw within 12 hours of head injury is the first listed.
NCT02439736 lists 7 locations in 5 states (Virginia, Other, California).
Frequently Asked Questions
What is clinical trial NCT02439736 about?
NCT02439736 is a clinical study titled "Evaluation OF Biomarkers OF Traumatic Brain Injury Extension Study". The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely with traumatic brain in...
What is the current status of trial NCT02439736?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2015-06. Estimated completion is 2016-11.
What conditions does trial NCT02439736 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT02439736?
The interventions under investigation include: Blood draw within 12 hours of head injury (OTHER).
Who is sponsoring clinical trial NCT02439736?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02439736 being conducted?
This trial has 7 study locations across California, Michigan, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02439736's enrollment target sits among peer trials
119 60th of 171 higher than 111 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia